Medication Management in Adults With Intellectual and Developmental Disabilities: Psychiatric Pharmacists in Primary Care.

Moon et al. (2024) parked a psychiatric pharmacist inside a primary-care clinic for adults with intellectual and developmental disabilities (IDD).

Over 20 weeks the pharmacist reviewed meds for 97 patients and logged every action taken.

The team recorded 308 pharmacist-driven interventions. Most were full medication reviews.

The service ran smoothly, showing a practical way to fold specialist drug checks into everyday primary care.

Bigby et al. (2009) audited charts in a residential program and saw that only 44 % of reflux-drug orders had a clear reason. Esther’s pharmacist model answers that gap by adding a second set of expert eyes.

Wilson et al. (2020) tested a wider care-coordination program and found small gains in spotting heart and cholesterol problems. The pharmacist service zooms in on medicines, giving a tighter, easier-to-copy fix.

Shawahna et al. (2017) looks like a clash: their community pharmacists felt unprepared to counsel on autism meds. The difference is role and setting. Ramzi asked general pharmacists in Palestine; Esther used specialist pharmacists inside U.S. clinics. Training plus daily IDD exposure explains the confidence gap.

If you serve adults with IDD, you can ask your clinic to embed a psychiatric pharmacist for one day a week. The move costs one salary but caught over 300 drug issues in five months. Start by listing every patient on three or more psychotropics and offer that list to the pharmacist first.